Search Results - "BEARMAN, Scott I"

Intensive Dose-Dense Compared With High-Dose Adjuvant Chemotherapy for High-Risk Operable Breast Cancer: Southwest Oncology Group/Intergroup Study 9623 by MOORE, Halle C. F, GREEN, Stephanie J, ELIAS, Anthony D, LIVINGSTON, Robert B, MARTINO, Silvana, GRALOW, Julie R, BEARMAN, Scott I, LEW, Danika, BARLOW, William E, HUDIS, Clifford, WOLFF, Antonio C, INGLE, James N, CHEW, Helen K

“…Southwest Oncology Group (SWOG)/Intergroup study 9623 was undertaken to compare treatment with an anthracycline-based adjuvant chemotherapy regimen followed by…”
Get full text

Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma: A Phase II Study of the Southwest Oncology Group (SWOG 9349) by BLAYNEY, Douglas W, LEBLANC, Michael L, GROGAN, Thomas, GAYNOR, Ellen R, CHAPMAN, Robert A, SPIRIDONIDIS, C. Harris, TAYLOR, Sarah A, BEARMAN, Scott I, MILLER, Thomas P, FISHER, Richard I

“…To test the hypothesis that therapy of intermediate- and high-grade (excluding Burkitt lymphoblastic) lymphoma with cyclophosphamide, doxorubicin, vincristine,…”
Get full text

Prognostic Analysis of Early Lymphocyte Recovery in Patients with Advanced Breast Cancer Receiving High-Dose Chemotherapy with an Autologous Hematopoietic Progenitor Cell Transplant by NIETO, Yago, SHPALL, Elizabeth J, MURPHY, James, JONES, Roy B, MCNIECE, Ian K, NAWAZ, Samia, BEAUDET, Julie, ROSINSKI, Steve, PELLOM, Julie, SLAT-VASQUEZ, Victoria, MCSWEENEY, Peter A, BEARMAN, Scott I

“…Purpose: The purpose of this study was to evaluate the prognostic effect of early posttransplant lymphocyte recovery in patients with advanced breast cancer…”
Get full text

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer by Flanigan, Robert C, Salmon, Sydney E, Blumenstein, Brent A, Bearman, Scott I, Roy, Vivek, McGrath, Patrick C, Caton, John R, Munshi, Nikhil, Crawford, E. David

“…Metastatic renal-cell cancer resists cytotoxic chemotherapy and radiotherapy but can respond to various forms of immunotherapy. This prospective, randomized…”
Get full text

Long-Term Analysis and Prospective Validation of a Prognostic Model for Patients with High-Risk Primary Breast Cancer Receiving High-Dose Chemotherapy by NIETO, Yago, NAWAZ, Samia, SHPALL, Elizabeth J, BEARMAN, Scott I, MURPHY, James, JONES, Roy B

“…Purpose: We described previously a prognostic model for high-risk primary breast cancer patients receiving high-dose chemotherapy (HDC). Such model included…”
Get full text

Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer by NIETO, Yago, VREDENBURGH, James J, JONES, Roy B, SHPALL, Elizabeth J, BEARMAN, Scott I, MCSWEENEY, Peter A, CHAO, Nelson, RIZZIERI, David, GASPARETTO, Christina, MATTHES, Steve, BARON, Anna E

“…Purpose: To evaluate the safety of concurrent treatment with trastuzumab and high-dose chemotherapy (HDC), using cyclophosphamide, cisplatin, and…”
Get full text

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome by Richardson, Paul G., Murakami, Carol, Jin, Zhezhen, Warren, Diane, Momtaz, Parisa, Hoppensteadt, Deborah, Elias, Anthony D., Antin, Joseph H., Soiffer, Robert, Spitzer, Thomas, Avigan, David, Bearman, Scott I., Martin, Paul L., Kurtzberg, Joanne, Vredenburgh, James, Chen, Allen R., Arai, Sally, Vogelsang, Georgia, McDonald, George B., Guinan, Eva C.

“…Veno-occlusive disease (VOD) is the most common regimen-related toxicity accompanying stem cell transplantation (SCT). Severe VOD complicated by multisystem…”
Get full text

Transplantation of ex vivo expanded cord blood by Shpall, Elizabeth J, Quinones, Ralph, Giller, Roger, Zeng, Chan, Baron, Anna E, Jones, Roy B, Bearman, Scott I, Nieto, Yago, Freed, Brian, Madinger, Nancy, Hogan, Christopher J, Slat-Vasquez, Vicki, Russell, Peggy, Blunk, Betsy, Schissel, Deborah, Hild, Elaine, Malcolm, Janet, Ward, William, McNiece, Ian K

“…Umbilical cord blood (CB) from unrelated donors is increasingly used to restore hematopoiesis after myeloablative therapy. CB transplants are associated with…”
Get full text

Renal dysfunction in allogeneic hematopoietic cell transplantation by Parikh, Chirag R., McSweeney, Peter A., Korular, Didem, Ecder, Tevfik, Merouani, Aicha, Taylor, Jeremy, Slat-Vasquez, Vicki, Shpall, Elizabeth J., Jones, Roy B., Bearman, Scott I., Schrier, Robert W.

“…Renal dysfunction in allogeneic hematopoietic cell transplantation. Allogeneic hematopoietic cell transplantation (HCT), formerly called bone marrow…”
Get full text

Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer by McNiece, Ian, Jones, Roy, Bearman, Scott I., Cagnoni, Pablo, Nieto, Yago, Franklin, Wilbur, Ryder, John, Steele, Andrea, Stoltz, Judy, Russell, Peggy, McDermitt, Janet, Hogan, Christopher, Murphy, James, Shpall, Elizabeth J.

“…Ex vivo expanded peripheral blood progenitor cells (PBPCs) have been proposed as a source of hematopoietic support to decrease or eliminate the period of…”
Get full text

Prognostic Model for Relapse After High-Dose Chemotherapy With Autologous Stem-Cell Transplantation for Stage IV Oligometastatic Breast Cancer by Nieto, Y.

Get full text

Use of stem cell factor to mobilize hematopoietic progenitors by Bearman, S I

“…Stem cell factor (SCF) is a multipotent growth factor that plays a role in the growth and development of hematopoietic cells, spermatocytes, melanocytes, and…”
Get more information

Veno-occlusive disease of the liver by Bearman, Scott I

“…The success of high-dose cytoreductive strategies depends not only on antitumor activity but also on the tolerability of treatment. Although advances in…”
Get full text

Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation by NIETO, Y, CAGNONI, P. J, JONES, R. B, NAWAZ, S, SHPALL, E. J, YERUSHALMI, R, COOK, B, RUSSELL, P, MCDERMIT, J, MURPHY, J, BEARMAN, S. I

“…To ascertain the predictive value of Her-2/neu overexpression and p53 mutations, assessed by immunohistochemistry, in high-risk primary breast cancer (HRPBC)…”
Get full text

Reduced-intensity allogeneic stem cell transplantation by Bearman, Scott I

“…The aim of reduced-intensity allogeneic stem cell transplantation is to exploit the graft-versus-tumor effect and reduce the toxicity associated with…”
Get more information

Acute Encephalopathy: A New Toxicity Associated with High-Dose Paclitaxel by Yago Nieto, Pablo J. Cagnoni, Scott I. Bearman, Elizabeth J. Shpall, Steven Matthes, Todd DeBoom, Anna Barón, Roy B. Jones

“…The purpose of this study was to describe acute encephalopathy as a new toxicity associated with paclitaxel, when it is delivered at high doses (≥600 mg/m 2…”
Get full text

A Predictive Model for Relapse in High-Risk Primary Breast Cancer Patients Treated with High-Dose Chemotherapy and Autologous Stem-Cell Transplant by NIETO, Y, CAGNONI, P. J, SHPALL, E. J, XUESHENG XU, MURPHY, J, VREDENBURGH, J, CHAO, N. J, BEARMAN, S. I, JONES, R. B

“…High-dose chemotherapy (HDCT) is currently under evaluation for high-risk primary breast cancer (HRPBC), defined by extensive axillary nodal involvement or…”
Get full text

Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy by Nieto, Yago, Shpall, Elizabeth J, Bearman, Scott I, Jones, Roy B

“…There are contradictory results regarding a potential increased responsiveness of younger women with high-risk primary breast cancer to high-dose compared with…”
Get full text

Phase II Trial of High-Dose Chemotherapy with Autologous Stem Cell Transplant for Stage IV Breast Cancer with Minimal Metastatic Disease by NIETO, Y, CAGNONI, P. J, SHPALL, E. J, MATTHES, S, BARON, A, JONES, R. B, BEARMAN, S. I

“…The purpose of this study was to assess the efficacy of high-dose chemotherapy (HDC) with autologous stem cell transplant in stage IV breast cancer patients…”
Get full text

NIH Consensus Breast Cancer Conference by Bearman, Scott I

Get full text